125 related articles for article (PubMed ID: 7858891)
1. Role of K+ channels in the vasodilator response to bradykinin in the rat heart.
Fulton D; McGiff JC; Quilley J
Br J Pharmacol; 1994 Nov; 113(3):954-8. PubMed ID: 7858891
[TBL] [Abstract][Full Text] [Related]
2. NO-independent vasodilation to acetylcholine in the rat isolated kidney utilizes a charybdotoxin-sensitive, intermediate-conductance Ca(++)-activated K+ channel.
Mieyal P; Fulton D; McGiff JC; Quilley J
J Pharmacol Exp Ther; 1998 May; 285(2):659-64. PubMed ID: 9580610
[TBL] [Abstract][Full Text] [Related]
3. Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat.
Rapacon M; Mieyal P; McGiff JC; Fulton D; Quilley J
Br J Pharmacol; 1996 Jul; 118(6):1504-8. PubMed ID: 8832078
[TBL] [Abstract][Full Text] [Related]
4. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat.
Fulton D; Quilley J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371
[TBL] [Abstract][Full Text] [Related]
5. Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
Fulton D; McGiff JC; Quilley J
J Pharmacol Exp Ther; 1996 Aug; 278(2):518-26. PubMed ID: 8768699
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nitric oxide and potassium channels in the bradykinin-induced vasodilatation in the rat kidney perfused ex situ.
Pompermayer K; Assreuy J; Vieira MA
Regul Pept; 2002 May; 105(3):155-62. PubMed ID: 11959369
[TBL] [Abstract][Full Text] [Related]
7. K(+)-induced vasodilation in the rat kidney is dependent on the endothelium and activation of K+ channels.
Quilley J; Qiu Y
Eur J Pharmacol; 2005 Jan; 508(1-3):193-9. PubMed ID: 15680271
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers.
Cowan CL; Cohen RA
J Pharmacol Exp Ther; 1992 Jan; 260(1):248-53. PubMed ID: 1731041
[TBL] [Abstract][Full Text] [Related]
9. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.
Bauersachs J; Hecker M; Busse R
Br J Pharmacol; 1994 Dec; 113(4):1548-53. PubMed ID: 7889312
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.
Fulton D; Mcgiff JC; Quilley J
J Pharmacol Exp Ther; 1998 Nov; 287(2):497-503. PubMed ID: 9808672
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter.
Sobey CG; Faraci FM
Am J Physiol; 1997 Jan; 272(1 Pt 2):H256-62. PubMed ID: 9038945
[TBL] [Abstract][Full Text] [Related]
12. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
Fulton D; McGiff JC; Wolin MS; Kaminski P; Quilley J
J Pharmacol Exp Ther; 1997 Feb; 280(2):702-9. PubMed ID: 9023282
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Champion HC; Kadowitz PJ
Am J Physiol; 1997 Jul; 273(1 Pt 2):R414-22. PubMed ID: 9249580
[TBL] [Abstract][Full Text] [Related]
14. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.
Fulton D; McGiff JC; Quilley J
Br J Pharmacol; 1992 Nov; 107(3):722-5. PubMed ID: 1472970
[TBL] [Abstract][Full Text] [Related]
15. Involvement of K+ channel permeability changes in the L-NAME and indomethacin resistant part of adenosine-5'-O-(2-thiodiphosphate)-induced relaxation of pancreatic vascular bed.
Hillaire-Buys D; Chapal J; Linck N; Blayac JP; Petit P; Loubatières-Mariani MM
Br J Pharmacol; 1998 May; 124(1):149-56. PubMed ID: 9630354
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypercholesterolemia on Ca(2+)-dependent K(+) channel-mediated vasodilatation in vivo.
Jeremy RW; McCarron H
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1600-8. PubMed ID: 11009446
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450-dependent effects of bradykinin in the rat heart.
Fulton D; Mahboubi K; McGiff JC; Quilley J
Br J Pharmacol; 1995 Jan; 114(1):99-102. PubMed ID: 7712035
[TBL] [Abstract][Full Text] [Related]
18. The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide.
Oyekan AO
Eur J Pharmacol; 1995 Apr; 277(2-3):123-32. PubMed ID: 7493599
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide synthase inhibitors, L-NG-nitroarginine and L-NG-nitroarginine methyl ester, on responses to vasodilators of the guinea-pig coronary vasculature.
Vials A; Burnstock G
Br J Pharmacol; 1992 Oct; 107(2):604-9. PubMed ID: 1384916
[TBL] [Abstract][Full Text] [Related]
20. Cryptolepine-induced vasodilation in the isolated perfused kidney of the rat: role of G-proteins, K+ and Ca2+ channels.
Oyekan AO
Eur J Pharmacol; 1995 Oct; 285(1):1-9. PubMed ID: 8846804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
